Original language | English |
---|---|
Pages (from-to) | 688-689 |
Number of pages | 2 |
Journal | American Journal of Gastroenterology |
Volume | 117 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1 2022 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: American Journal of Gastroenterology, Vol. 117, No. 4, 01.04.2022, p. 688-689.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Reply to Li, Henry, and Nguyen
AU - Khalili, Mandana
AU - Kleiner, David E.
AU - King, Wendy C.
AU - Sterling, Richard K.
AU - Ghany, Marc G.
AU - Chung, Raymond T.
AU - Bhan, Atul K.
AU - Rosenthal, Philip
AU - Lisker-Melman, Mauricio
AU - Ramachandran, Rageshree
AU - Lok, Anna S.
N1 - Funding Information: Financial support: The HBRN was funded as a cooperative agreement between the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the following investigators: Lewis R. Roberts, MB, ChB, PhD (U01-DK082843); Anna Suk-Fong Lok, MD (U01-DK082863); Steven H. Belle, PhD, MScHyg (U01-DK082864); Kyong-Mi Chang, MD (U01-DK082866); Michael W. Fried, MD (U01-DK082867); Adrian M. Di Bisceglie, MD (U01-DK082871); William M. Lee, MD (U01-DK082872); Harry L. A. Janssen, MD, PhD (U01-DK082874); Daryl T-Y Lau, MD, MPH (U01-DK082919); Richard K. Sterling, MD, MSc (U01-DK082923); Steven-Huy B. Han, MD (U01-DK082927); Robert C. Carithers, MD (U01-DK082943); Mandana Khalili, MD (U01-DK082944); and Kathleen B. Schwarz, MD (U01-DK082916); an interagency agreement with NIDDK: Lilia M. Ganova-Raeva, PhD (A-DK-3002-001); and support from the intramural program, NIDDK, NIH: Marc G. Ghany, MD, and NCI, NIH: David E. Kleiner MD, PhD. Additional funding to support this study was provided to Kyong-Mi Chang, MD, the Immunology Center, (NIH/NIDDK Center of Molecular Studies in Digestive and Liver Diseases P30DK50306, NIH Public Health Service Research Grant M01-RR00040); Richard K. Sterling, MD, MSc (UL1TR000058, NCATS, National Center for Advancing Translational Sciences, NIH); Mandana Khalili, MD (CTSA Grant No. UL1TR000004); Michael W. Fried, MD (CTSA Grant No. UL1TR001111); Anna Suk-Fong Lok (CTSA Grant No. UL1RR024986 and U54TR001959); and Kathleen B. Schwarz, MD (CTSA Grant No. UL1TR000423). Additional support was provided by Gilead Sciences and Roche Molecular Systems by a CRADA through the NIDDK. M.K. was also partially supported by K24AA022523. Funding Information: Potential competing interests: M.K. is a recipient of a research grant (to her institution) from Gilead Sciences and Intercept Pharmaceuticals, and she has served as consultant for Gilead Sciences. Raymond Chung has research grants (to institution) from Gilead, AbbVie, BMS, Merck, Boehringer, Roche, Janssen, and from the MGH Research Scholars Program. P.R. has research support from Gilead Sciences, AbbVie, Merck, Arrowhead, and Retrophin and consults for Gilead, AbbVie, Retrophin, Albireo, Mirum, Audentes, and Dicerna. M.L.-M. serves on the speaker bureau for AbbVie, Gilead Sciences, and SimplySpeaking. R.K.S. has received research grants from Abbott, AbbVie, Gilead, and Roche and serves on the data safety and monitoring board for Pfizer and Baxter. A.S.L. has received research grant support (to the University of Michigan) from Bristol-Myers Squibb, Gilead, and TARGET and has served on advisory panels of Gilead and TARGET. W.C.K. has received funding from Abbott. M.G.G., A.K.B., R.R., and D.K. do not have any disclosures relevant to this project.
PY - 2022/4/1
Y1 - 2022/4/1
UR - http://www.scopus.com/inward/record.url?scp=85128159816&partnerID=8YFLogxK
U2 - 10.14309/ajg.0000000000001662
DO - 10.14309/ajg.0000000000001662
M3 - Letter
C2 - 35158369
AN - SCOPUS:85128159816
SN - 0002-9270
VL - 117
SP - 688
EP - 689
JO - American Journal of Gastroenterology
JF - American Journal of Gastroenterology
IS - 4
ER -